Johnson & Johnson has agreed to pay $2 billion and plead guilty to a misdemeanor in a deal that would settle the U.S. government's investigations into the marketing of antipsychotic Risperdal.
http://stream.wsj.com/story/latest-headlines/SS-2-63399/SS-2-372500/